287 related articles for article (PubMed ID: 35220958)
21. Interstitial lung disease in Sjögren's syndrome: a clinical review.
Luppi F; Sebastiani M; Silva M; Sverzellati N; Cavazza A; Salvarani C; Manfredi A
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):291-300. PubMed ID: 33095142
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome.
Weng L; Chen Y; Liang T; Lin Y; Liu D; Yu C; Hu Y; Lui W; Liu Y; Chen X; Li Q; Ge S; Ascherman DP; Chen J
Eur J Med Res; 2022 Oct; 27(1):199. PubMed ID: 36217184
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome.
Lin W; Xin Z; Ning X; Li Y; Ren X; Su Y; Liu M; Guo S; Yang L; Liu Y; Zhang F; Zhang W
Clin Rheumatol; 2021 Oct; 40(10):4081-4087. PubMed ID: 33914202
[TBL] [Abstract][Full Text] [Related]
24. The respiratory manifestations in patients with primary Sjögren's syndrome: is interstitial lung disease related to disease activity?
Işık ÖÖ; Yazıcı A; Çefle A
Turk J Med Sci; 2022 Apr; 52(5):1737-1743. PubMed ID: 36422505
[TBL] [Abstract][Full Text] [Related]
25. Clinical course and risk factors for development and progression of interstitial lung disease in primary Sjögren's syndrome.
Lee KA; Nam BD; Hwang JH; Kim HS
Sci Rep; 2023 Jun; 13(1):9189. PubMed ID: 37280251
[TBL] [Abstract][Full Text] [Related]
26. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
[TBL] [Abstract][Full Text] [Related]
27. Sjögren's syndrome-associated interstitial lung disease: A multicenter study.
Reina D; Roig Vilaseca D; Torrente-Segarra V; Cerdà D; Castellví I; Díaz Torné C; Moreno M; Narváez J; Ortiz V; Blavia R; Martín-Baranera M; Corominas H
Reumatol Clin; 2016; 12(4):201-5. PubMed ID: 26573882
[TBL] [Abstract][Full Text] [Related]
28. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.
Enomoto Y; Takemura T; Hagiwara E; Iwasawa T; Fukuda Y; Yanagawa N; Sakai F; Baba T; Nagaoka S; Ogura T
PLoS One; 2013; 8(9):e73774. PubMed ID: 24040065
[TBL] [Abstract][Full Text] [Related]
30. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
[TBL] [Abstract][Full Text] [Related]
31. Serum bilirubin levels in primary Sjögren's syndrome: an association with interstitial lung disease.
Peng YF; Lu FY; Ma LY
BMC Pulm Med; 2023 Sep; 23(1):366. PubMed ID: 37777728
[TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
Shi L; Fu Q; Chen N; Liu R; Zheng Y
Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary involvement in primary Sjögren's syndrome: contribution of the different means in the systematic investigation.
Jridi M; Cherif Y; Derbal S; Dahmen FB; Abdallah M
Pan Afr Med J; 2023; 46():42. PubMed ID: 38188883
[TBL] [Abstract][Full Text] [Related]
34. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology.
Sambataro G; Ferro F; Orlandi M; Sambataro D; Torrisi SE; Quartuccio L; Vancheri C; Baldini C; Matucci Cerinic M
Autoimmun Rev; 2020 Feb; 19(2):102447. PubMed ID: 31843713
[TBL] [Abstract][Full Text] [Related]
35. The ratio of neutrophil to lymphocyte predicts interstitial lung disease and its prognosis in patients with primary Sjögren's syndrome: a retrospective analysis.
Zhang K; Li W; He C; He X; Hou J
Ann Palliat Med; 2021 Jun; 10(6):6493-6501. PubMed ID: 34154345
[TBL] [Abstract][Full Text] [Related]
36. Fibrosing interstitial lung disease in primary Sjogren syndrome.
Manfredi A; Vacchi C; DellaCasa G; Cerri S; Cassone G; Di Cecco G; Luppi F; Salvarani C; Sebastiani M
Joint Bone Spine; 2021 Dec; 88(6):105237. PubMed ID: 34118430
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary manifestations of Sjögren's syndrome.
Flament T; Bigot A; Chaigne B; Henique H; Diot E; Marchand-Adam S
Eur Respir Rev; 2016 Jun; 25(140):110-23. PubMed ID: 27246587
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Kamiya Y; Fujisawa T; Kono M; Nakamura H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Sumikawa H; Johkoh T; Yasui H; Hozumi H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
Respir Med; 2019 Nov; 159():105811. PubMed ID: 31710871
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren's syndrome: A systematic review and meta-analysis.
He C; Chen Z; Liu S; Chen H; Zhang F
Int J Rheum Dis; 2020 Aug; 23(8):1009-1018. PubMed ID: 32588976
[TBL] [Abstract][Full Text] [Related]
40. Rituximab therapy in primary Sjögren's syndrome with interstitial lung disease: a retrospective cohort study.
Chen MH; Chen CK; Chou HP; Chen MH; Tsai CY; Chang DM
Clin Exp Rheumatol; 2016; 34(6):1077-1084. PubMed ID: 27607895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
